Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 7051.24% is 639% above its 5-year average of -1307.10%, near the high end of its 5-year range (-29063.16%–7554.72%).
1089.53% above its 12-month average of -712.58%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
7051.24%
NET PROFIT MARGIN AVG TTM
-712.58%
NET PROFIT MARGIN AVG 3Y
-2257.72%
NET PROFIT MARGIN AVG 5Y
-1307.10%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1089.53%
CURRENT VS 3Y AVG
+412.32%
CURRENT VS 5Y AVG
+639.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 789 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Rallybio Corporation
Market Cap
$90.32M
Net Profit Margin
7051.24%
TTM Avg
-712.58%
3Y Avg
-2257.72%
5Y Avg
-1307.10%
Market Cap
$90.25M
Net Profit Margin
-39.96%
TTM Avg
-45.40%
3Y Avg
-116.56%
5Y Avg
-242.44%
Market Cap
$90.96M
Net Profit Margin
0.00%
TTM Avg
-9.81%
3Y Avg
-113.18%
5Y Avg
-75.45%
Market Cap
$89.68M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.60M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$91.48M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.34M
Net Profit Margin
2.57%
TTM Avg
-5.95%
3Y Avg
-14.59%
5Y Avg
-10.91%
Market Cap
$86.54M
Net Profit Margin
-269.42%
TTM Avg
-19.58%
3Y Avg
-904.79%
5Y Avg
-881.91%
Market Cap
$93.48M
Net Profit Margin
-1.41%
TTM Avg
0.88%
3Y Avg
1.31%
5Y Avg
1.31%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rallybio Corporation (RLYB) | $90.32M | 7051.24% | -712.58% | -2257.72% | -1307.10% |
| electroCore, Inc. (ECOR)vs › | $90.25M | -39.96% | -45.40% | -116.56% | -242.44% |
| Equillium, Inc. (EQ)vs › | $90.96M | 0.00% | -9.81% | -113.18% | -75.45% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biomea Fusion, Inc. (BMEA)vs › | $91.48M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImmuCell Corporation (ICCC)vs › | $89.34M | 2.57% | -5.95% | -14.59% | -10.91% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.54M | -269.42% | -19.58% | -904.79% | -881.91% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.48M | -1.41% | 0.88% | 1.31% | 1.31% |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 6.21% | 8.02% | -5.41% | -4.66% |
Operating Margin
-3270.9%
Net Profit Margin
7051.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | -3904.72% |
| 2025-12-31 | -2636.04% |
| 2025-09-30 | 7554.72% |
| 2025-06-30 | -4576.89% |
| 2025-03-31 | -4452.36% |
| 2024-12-31 | -29063.16% |
| 2024-09-30 | -3834.78% |
| 2024-06-30 | -5430.10% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
